Nimodipine 30 mg/1 (Nimodipine CAPSULE, LIQUID FILLED) 30 mg/1

Nimodipine 30 mg/1 is a calcium channel blocker used for managing certain vascular conditions. This liquid-filled capsule is designed for oral administration and is manufactured by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Strength

30 mg/1

Pack Size

3 BLISTER PACK in 1 CARTON (23155-512-30) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK

Manufacturer / TM Owner

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nimodipine 30 mg/1 is commonly used to improve blood flow in the brain. It is often prescribed for conditions related to cerebral vascular health. People may ask, 'What is nimodipine used for?' primarily in scenarios involving vascular health support.

Side Effects

Nimodipine 30 mg/1 may cause common effects such as headache, dizziness, or nausea. Some users report feeling lightheaded or experiencing flushing. These effects can vary widely among individuals.

Precautions & Warnings

Handle nimodipine 30 mg/1 with care, especially if you have a history of low blood pressure or liver issues. Always follow the guidance of a healthcare professional regarding its use. Store in a cool, dry place away from children.

Avoid Interactions

Nimodipine 30 mg/1 may interact with other medications, including certain blood pressure drugs and CYP inhibitors. Alcohol consumption should be avoided as it may enhance certain effects. Consult a healthcare provider before combining with other treatments.

Frequently Asked Questions

Nimodipine is used to improve blood flow in the brain, often for conditions related to cerebral vascular health.

Nimodipine 30 mg/1 is taken orally, typically with or without food. Follow the instructions provided by your healthcare professional.

Common side effects may include headache, dizziness, nausea, and lightheadedness. These effects can vary among individuals.

It is generally advised to avoid alcohol while taking nimodipine, as it may enhance certain effects.

Store nimodipine in a cool, dry place away from children and direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.